Ask for Zero Contrast Angioplasty, protect your kidneys

 

Zero-Contrast Angioplasty: An Option for Patients at Risk of Kidney Injury

Published: 16 June 2022 | Bhavesh Roy

Quick Summary

Coronary angioplasty commonly uses iodine-based contrast material to help doctors see the coronary arteries during an X-ray-guided procedure. Contrast exposure can contribute to acute kidney injury in some patients, particularly those with existing kidney impairment or other risk factors.

Zero-contrast angioplasty is a specialised form of percutaneous coronary intervention (PCI) in which the operator performs the intervention without injecting contrast during the procedure. Intravascular ultrasound (IVUS), previous angiographic images and other procedural landmarks may help guide treatment.

This technique may be considered for selected patients at high risk of kidney injury when angioplasty is otherwise indicated. It requires appropriate equipment, expertise and careful planning. It does not eliminate all kidney risks or the other risks of angioplasty, and the team must be prepared to use contrast if it becomes necessary for patient safety.

Patients should discuss their kidney function, treatment options, procedural risks and the availability of an experienced team with their cardiologist. Necessary treatment for a serious coronary condition should not be delayed solely to pursue a zero-contrast approach.

Introduction

Patients who are advised to undergo coronary angiography or angioplasty often have questions about contrast material and kidney safety. These concerns can be particularly important for someone who has chronic kidney disease, has recently experienced acute kidney injury or previously developed a kidney problem after a contrast-enhanced procedure.

Coronary angiography uses X-ray imaging and contrast material to show the arteries supplying the heart. Angioplasty is a catheter-based treatment used to improve blood flow through a narrowed or blocked coronary artery when revascularisation is appropriate. Contrast helps the operator see the coronary anatomy during these procedures.

For patients at increased risk of kidney injury, the clinical team may consider ways to reduce the amount of contrast used. These can include carefully planned conventional angiography, ultra-low-contrast techniques or, in selected cases, zero-contrast PCI guided by intravascular imaging.

Zero-contrast angioplasty is a specialised technique, not a universal replacement for conventional angioplasty. It requires careful assessment of the coronary anatomy and the patient’s condition. This article explains why contrast is used, how contrast-associated kidney injury is assessed, how IVUS can guide a zero-contrast procedure and which patients may be considered for this approach.

Table of Contents

  1. Why Is Contrast Used During Angioplasty?
  2. What Are the Possible Effects of Contrast on the Kidneys?
  3. How Can the Risk of Kidney Injury Be Reduced?
  4. What Is Zero-Contrast Angioplasty?
  5. How Does IVUS Guide Angioplasty?
  6. IVUS-Guided PCI vs. Zero-Contrast PCI
  7. Is IVUS Safe?
  8. An Illustrative Patient Example
  9. Who May Be Considered for Zero-Contrast Angioplasty?
  10. What Are the Limitations of Zero-Contrast PCI?
  11. Frequently Asked Questions
  12. Key Takeaways
  13. Conclusion

1. Why Is Contrast Used During Angioplasty?

Coronary angiography and angioplasty are performed using X-ray imaging. The coronary arteries are relatively small, so contrast material is commonly injected to outline their inner channels and make them visible on the X-ray images.

What is contrast material?

Most coronary angiography and PCI procedures use an iodine-based contrast agent. The agent absorbs X-rays differently from the surrounding tissues, allowing the coronary artery lumen to appear more clearly on the images.

These images help the operator identify the location of a narrowing, assess the vessel’s course and plan the procedure. During angioplasty, they can also help guide balloons, guidewires and stents and assess blood flow after treatment.

Why is contrast useful during angioplasty?

Contrast-enhanced images provide important information about:

  • The location and apparent severity of a coronary narrowing.
  • The length and shape of a lesion.
  • The course of the coronary artery and the location of its branches.
  • Guidewire and device position during the procedure.
  • Blood flow and possible complications after treatment.

Contrast imaging is an important tool, but it does not provide every detail about the vessel wall or necessarily determine how much an intermediate narrowing restricts blood flow. In selected patients, intravascular imaging or physiological measurements can supply additional information.

Read more about coronary angiography and coronary angioplasty.

2. What Are the Possible Effects of Contrast on the Kidneys?

Contrast material used during coronary procedures can be associated with acute kidney injury in some patients. Acute kidney injury is a sudden deterioration in kidney function that may be identified through changes in blood tests, urine output or other clinical findings.

Kidney function is commonly assessed using blood tests such as serum creatinine, alongside estimated glomerular filtration rate (eGFR), urine output and the patient’s overall clinical condition. Creatinine is a useful marker, but it does not tell the whole story about kidney health by itself.

Does contrast always cause kidney injury?

No. A change in kidney function after a contrast-enhanced procedure does not automatically mean that contrast caused the problem.

The term contrast-associated acute kidney injury describes kidney injury occurring around the time of contrast exposure, without necessarily proving that contrast was the cause. The term contrast-induced acute kidney injury is used when a causal relationship is considered to have been established.

Other factors may contribute to kidney injury around a coronary procedure, including low blood pressure, reduced blood flow to the kidneys, acute illness, heart failure, dehydration and pre-existing kidney disease. The clinical team considers these factors when assessing an individual’s risk.

Who may have a higher risk?

Risk assessment is particularly important for people with:

  • Chronic kidney disease or significantly reduced eGFR.
  • A recent episode of acute kidney injury.
  • Previous kidney deterioration associated with a contrast-enhanced procedure.
  • Dehydration, low blood pressure or other causes of reduced kidney perfusion.
  • Severe heart failure or an acute cardiovascular illness.
  • Diabetes, particularly when accompanied by kidney impairment or other risk factors.
  • A likely need for a large amount of contrast or repeated contrast exposure.

Having diabetes does not automatically mean that a patient will develop contrast-associated kidney injury. The level of kidney function, the clinical situation and other risk factors are important in estimating risk.

Can kidney injury be severe?

Yes. Some cases of acute kidney injury are temporary, while others can be more serious and require additional treatment. In severe circumstances, temporary or longer-term dialysis may be needed. The likelihood depends on the patient’s condition and the cause and severity of the kidney injury.

However, patients should not assume that contrast exposure inevitably leads to kidney failure. The goal is to balance the kidney-related risks of the procedure against the potential harm of leaving important coronary disease untreated.

3. How Can the Risk of Kidney Injury Be Reduced?

When coronary angiography or angioplasty is necessary, the healthcare team can take measures to reduce kidney risk. The appropriate strategy depends on kidney function, heart function, urgency, fluid status and the procedure being planned.

Assess kidney function and overall risk

Doctors may review serum creatinine, eGFR, recent kidney test results, fluid status, blood pressure and relevant medical conditions before the procedure. The team also considers the urgency of the coronary problem and the amount of contrast that may be needed.

Use the minimum contrast required for safe treatment

Contrast exposure can sometimes be reduced by planning the procedure carefully, reviewing previous angiographic images, limiting unnecessary injections and using intravascular imaging where appropriate.

Ultra-low-contrast PCI uses a very small amount of contrast, while zero-contrast PCI aims to perform the intervention without contrast injections during the PCI itself. These approaches require specialised planning and are not appropriate for every patient or lesion.

Individualise hydration

Intravenous fluids may help reduce kidney risk in selected patients. The amount and timing must be determined according to kidney function, blood pressure, hydration status and heart function.

Giving too much fluid can be harmful to some people, particularly those with heart failure or a tendency to retain fluid. Patients should therefore not increase fluid intake or request a fixed hydration regimen without medical advice.

Review medicines and other precautions

The care team may review medicines that could affect kidney function or fluid balance and decide whether any temporary changes are needed. The correct approach depends on the patient’s prescription and medical condition.

There is no single preventive medicine that guarantees protection against contrast-associated kidney injury. Decisions about medication, hydration, contrast choice and post-procedure monitoring should follow clinical guidance and individual assessment.

Important: If a coronary procedure is urgently required to treat a heart attack or another serious condition, fear of kidney injury should not lead to an unsafe delay. The team should reduce kidney risk as far as reasonably possible while providing necessary treatment.

4. What Is Zero-Contrast Angioplasty?

Zero-contrast angioplasty is a specialised form of percutaneous coronary intervention in which the operator performs the planned coronary intervention without injecting contrast during the procedure. It is most often discussed for selected patients at high risk of kidney injury.

The technique commonly relies on intravascular ultrasound, previous coronary angiographic images and carefully established landmarks to guide the intervention.

How can angioplasty be performed without contrast injections?

In conventional PCI, contrast images are used to identify the coronary anatomy, assess device position and confirm the result. In a zero-contrast approach, the team plans how to obtain this information without routine contrast injections during the intervention.

Depending on the case, the operator may use:

  • Previous coronary angiographic images to understand the vessel anatomy.
  • Intravascular ultrasound to assess vessel dimensions, plaque and stent position.
  • Guidewires positioned in relevant branches as procedural landmarks.
  • Fluoroscopy and other available procedural information to guide device movement.
  • Selected physiological or imaging assessments to evaluate the result when appropriate.

IVUS helps the operator view the vessel from inside, but the entire procedure still requires specialised training, equipment and careful coordination. Not every coronary anatomy provides equally clear landmarks, and not all procedures can be completed safely without contrast.

Does zero-contrast angioplasty mean no contrast was ever used?

Not necessarily. A patient may have undergone diagnostic coronary angiography previously, and that earlier procedure may have used contrast. Those images may then be used to plan a later zero-contrast PCI.

Therefore, the term usually describes the contrast strategy used during the intervention, not necessarily the entire diagnostic and treatment pathway. Patients should ask the treating team whether the proposed plan involves zero contrast during PCI, ultra-low contrast, or contrast minimisation more generally.

Does zero contrast eliminate kidney risk?

Zero-contrast PCI avoids additional iodinated contrast exposure during the intervention, which may be valuable for selected high-risk patients. However, it does not remove every possible cause of acute kidney injury.

Blood pressure changes, acute illness, dehydration, heart failure and other factors can still affect kidney function. The patient also remains exposed to the usual risks of PCI, including vascular injury, bleeding, coronary complications and heart rhythm problems.

Zero-contrast PCI should therefore be considered a way to reduce one potential source of harm—not a guarantee against kidney injury or procedural complications.

5. How Does IVUS Guide Angioplasty?

IVUS stands for intravascular ultrasound. It uses ultrasound to generate images from inside a blood vessel. During coronary intervention, a specialised catheter is passed through the coronary artery over a guidewire to obtain cross-sectional images of the vessel.

What information does IVUS provide?

Depending on the image quality and the anatomy, IVUS can help the operator assess:

  • The dimensions of the coronary artery.
  • The size and distribution of plaque within the vessel wall.
  • The location and extent of calcification.
  • Potential landing zones for the stent.
  • Stent expansion and its position against the vessel wall after deployment.

This information can help the operator select appropriately sized equipment and assess the result. Intravascular imaging is particularly useful in selected complex coronary interventions, but its value depends on the clinical circumstances and the quality of the images obtained.

How is IVUS different from angiography?

Conventional angiography primarily shows the contrast-filled lumen of the artery from different viewing angles. IVUS provides cross-sectional images from inside the vessel, offering additional information about vessel size, plaque and stent deployment.

The two methods provide different kinds of information. IVUS does not automatically replace all angiographic or physiological assessment in every procedure, and an operator must consider whether the available images and landmarks are sufficient to proceed safely.

Read more about IVUS and optical coherence tomography (OCT).

6. IVUS-Guided PCI vs. Zero-Contrast PCI

Although the terms are sometimes used together, IVUS-guided PCI and zero-contrast PCI are not exactly the same thing.

Feature IVUS-guided PCI Zero-contrast PCI
Use of IVUS IVUS helps assess vessel anatomy and guide stent treatment. IVUS is commonly used as a key tool to guide the intervention.
Contrast use May still include conventional contrast injections throughout the procedure. Aims to avoid contrast injections during the intervention.
Primary procedural goal Use intravascular imaging to improve information available for PCI. Guide PCI while minimising or eliminating additional contrast exposure during the procedure.
Potential role May be useful in selected routine and complex coronary interventions. May be considered particularly for selected patients at high risk of kidney injury.
Requirements Appropriate imaging equipment and expertise. Careful planning, suitable anatomy and landmarks, IVUS expertise and a safe strategy for responding to complications.

IVUS can be used in both approaches. The defining difference is the contrast strategy, not whether IVUS is present.

Why isn’t zero-contrast PCI used in every patient?

Zero-contrast PCI is technically demanding and may require a team familiar with the technique, access to IVUS equipment and the ability to interpret previous angiographic images. The complexity of the blockage and the need to confirm the result also influence feasibility.

There may be additional equipment costs, and the procedure may not be suitable for every coronary anatomy. In some cases, a small amount of contrast may become necessary to clarify anatomy or manage a complication.

The objective is to choose the safest appropriate treatment. A zero-contrast approach should not be pursued at the expense of adequate assessment or procedural safety.

7. Is IVUS Safe?

IVUS uses ultrasound rather than ionising radiation to form its internal images. It is an established tool in coronary intervention and can provide useful information about the vessel and the stent.

However, saying that IVUS has no possible adverse effects would be too absolute. The ultrasound itself is not the same as an X-ray imaging method, but the catheter and guidewire must still be passed through the coronary artery.

As with other catheter-based coronary techniques, there are potential risks from device manipulation, including vessel injury or other procedural complications. The likelihood depends on the patient’s anatomy, the procedure and the circumstances in which IVUS is used.

IVUS also does not remove the other risks of angioplasty, such as bleeding at the access site, coronary complications or heart rhythm problems. It should be used by a team trained in the technique and when the additional information is clinically useful.

8. An Illustrative Patient Example

The original article describes a patient who had undergone angioplasty at another centre and subsequently developed acute kidney injury requiring dialysis. The patient’s kidney function later recovered, but further coronary treatment was still considered necessary for another significant blockage.

According to that account, an IVUS-guided zero-contrast approach was chosen for the subsequent intervention because of concern about another contrast exposure.

This example illustrates why a contrast-minimising strategy may be discussed when coronary treatment is necessary for a patient with a history of serious kidney injury. However, an individual case cannot establish the likely outcome for every patient, and the details of the original case have not been independently verified for this article.

In practice, the decision would depend on the patient’s current kidney function, the coronary anatomy, the urgency of treatment, previous angiographic images and the team’s expertise. The fact that zero-contrast PCI was feasible in one case does not guarantee that it will be appropriate or successful in another.

9. Who May Be Considered for Zero-Contrast Angioplasty?

Zero-contrast PCI may be considered when coronary intervention is clinically indicated and reducing additional contrast exposure is particularly important. The following are examples of situations in which the team may evaluate this option.

  • Advanced chronic kidney disease: Patients with substantially reduced eGFR may have an increased risk of kidney complications and may benefit from a carefully planned contrast-minimising strategy.
  • Recent acute kidney injury: Patients whose kidney function has recently deteriorated may require individualised planning before further contrast exposure.
  • Previous contrast-associated kidney injury: A history of kidney injury after a contrast-enhanced procedure may influence the plan for a subsequent intervention.
  • Multiple risk factors for kidney injury: The combination of kidney impairment, acute illness, haemodynamic instability or other relevant factors may prompt consideration of lower-contrast techniques.
  • Selected patients requiring complex coronary intervention: Some complex procedures may be feasible using intravascular imaging and previously obtained angiographic information, depending on the anatomy and the operator’s expertise.

Diabetes by itself does not automatically establish a need for zero-contrast angioplasty. Kidney function and the overall clinical risk are more informative than a single diagnosis in isolation.

What should be assessed before deciding?

The heart team may review kidney blood tests, previous angiographic images, the severity and location of the blockage, heart function, medications and the urgency of intervention. The team should also discuss the limitations of a zero-contrast approach and whether conventional or ultra-low-contrast PCI would be more appropriate.

Patients should ask what contrast strategy is proposed, why it is suitable for their particular case, how kidney risk will be managed and what will happen if contrast becomes necessary during the procedure.

10. What Are the Limitations of Zero-Contrast PCI?

Zero-contrast PCI may help avoid additional iodinated contrast during selected interventions, but it is not a simple substitution that every operator can perform in every setting.

Important considerations include:

  • Technical expertise: The operator must be familiar with interpreting IVUS, previous angiographic images and procedural landmarks.
  • Available equipment: Appropriate intravascular imaging equipment and a team experienced in the technique are needed.
  • Coronary anatomy: Some blockages or vessel configurations may be more difficult to treat without contrast injections.
  • Assessment of the result: The operator must have a safe way to assess the procedure and recognise complications.
  • Need for rescue contrast: If the patient’s safety requires clarification of the anatomy or management of a complication, contrast may still be necessary.
  • Underlying kidney risk: Even without contrast exposure during PCI, other causes of acute kidney injury remain possible.

Evidence supporting zero-contrast PCI includes small prospective studies and observational cohorts, particularly in patients with chronic kidney disease. These studies support feasibility in selected cases, but they do not prove that the approach is suitable for everyone or that it eliminates kidney injury and other complications.

The treatment objective remains to achieve an appropriate coronary result while minimising avoidable harm. If a zero-contrast plan is not clinically suitable, a carefully planned ultra-low-contrast or conventional procedure with risk-reduction measures may offer the better balance of safety and benefit.

11. Frequently Asked Questions

1. What is zero-contrast angioplasty?

Zero-contrast angioplasty is a specialised form of PCI performed without injecting contrast during the intervention. IVUS, previous angiographic images and other landmarks may be used to guide the procedure. It is considered in selected cases, often when the risk of kidney injury is a concern.

2. Does zero-contrast angioplasty protect the kidneys completely?

No. Avoiding additional contrast during PCI removes one potential source of kidney stress, but it does not eliminate every cause of acute kidney injury. Blood pressure changes, acute illness and other medical factors can still affect kidney function.

3. Is IVUS the same as zero-contrast angioplasty?

No. IVUS is an intravascular imaging technique. It can be used during conventional PCI with contrast or as part of a zero-contrast strategy. Zero-contrast PCI refers specifically to performing the intervention without contrast injections.

4. Can angioplasty be performed without any contrast?

In selected cases, experienced operators can perform PCI without injecting contrast during the procedure. Feasibility depends on the anatomy, previous angiographic information, imaging equipment and clinical circumstances. Contrast may still be required if it becomes necessary for safety.

5. Who may benefit from a zero-contrast approach?

It may be considered for selected patients with advanced chronic kidney disease, recent acute kidney injury or a history of serious kidney complications associated with contrast exposure. The decision also depends on the coronary blockage and whether an appropriately experienced team is available.

6. Is IVUS completely risk-free?

IVUS uses ultrasound to form images, but the catheter and guidewire still need to be passed through the coronary artery. Device-related or procedural complications are possible, and the overall risk depends on the clinical situation and operator expertise.

7. Does everyone with diabetes need zero-contrast angioplasty?

No. Diabetes may contribute to overall cardiovascular and kidney risk, but it does not automatically mean that a patient needs zero-contrast PCI. Kidney function, other risk factors, coronary anatomy and the clinical need for intervention should guide the decision.

8. Is zero-contrast PCI suitable during a heart attack?

The priority during a heart attack is timely, appropriate emergency care. Contrast reduction may be considered when feasible, but a zero-contrast strategy should not delay necessary diagnosis or revascularisation. The treating team decides how to balance kidney risk against the urgency of restoring blood flow.

9. Is zero-contrast PCI better than conventional angioplasty?

Not for every patient. It may offer an important advantage for selected patients at high risk of kidney injury, but it requires additional expertise and may not suit every anatomy. Conventional or ultra-low-contrast PCI may be more appropriate in other circumstances.

10. Can I request zero-contrast angioplasty if I have kidney disease?

You can ask your cardiologist whether a zero-contrast or ultra-low-contrast approach is feasible in your case. The decision should depend on your kidney function, previous angiography, the coronary blockage, procedural urgency, available equipment and the team’s experience.

12. Key Takeaways

  • Contrast helps clinicians visualise the coronary arteries during conventional angiography and angioplasty.
  • Contrast exposure can be associated with acute kidney injury, particularly in patients with significant kidney impairment or other risk factors.
  • Zero-contrast PCI aims to perform the intervention without contrast injections during the procedure; it does not necessarily mean that no contrast was used during previous diagnostic angiography.
  • IVUS provides images from inside the artery and may help guide selected zero-contrast procedures.
  • IVUS-guided PCI can still involve contrast, so IVUS guidance and zero-contrast PCI are not interchangeable terms.
  • Zero-contrast PCI may be considered for selected patients with advanced kidney disease or a previous episode of acute kidney injury, but it is not appropriate for everyone.
  • Hydration, contrast reduction and medication decisions must be tailored to the patient’s kidney function and overall medical condition.
  • Zero-contrast PCI does not eliminate all kidney or procedural risks. Necessary treatment should not be delayed if it is urgently required.

13. Conclusion

Zero-contrast angioplasty is a specialised approach that may help reduce additional contrast exposure during PCI for selected patients at increased risk of kidney injury. By using IVUS, previous coronary angiographic images and carefully established landmarks, experienced operators may be able to treat certain coronary blockages without contrast injections during the intervention.

However, the technique requires appropriate expertise and equipment, and its suitability depends on the patient’s coronary anatomy, kidney function and clinical circumstances. It cannot guarantee complete protection from acute kidney injury or other procedural complications.

Patients who are concerned about contrast exposure should discuss kidney-risk assessment, contrast-minimising strategies and available treatment options with their cardiologist. The aim is to make an informed decision that balances kidney safety with the need to treat coronary artery disease effectively.

Medical Disclaimer

This article provides educational information for the general public only. It does not replace professional medical advice, clinical diagnosis or treatment. Consult a qualified healthcare professional regarding your individual symptoms, kidney function, test results or treatment decisions. Do not delay urgent cardiac care because of concerns about contrast exposure. Seek immediate emergency medical care for severe or sudden chest pain, severe breathlessness, collapse or other symptoms that may indicate a medical emergency.